Chinese Journal of Pharmaceuticals
|
2023, 54(8): 1259-1264
• Pharmaceutical Management & Information •
Implications of the EMA-FDA Parallel Scientific Advice for China Communication System
Full
Affiliations
- School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198
Published: 2023-08-10
doi: 10.16522/j.cnki.cjph.2023.08.017
Outline
张思瑶, 梁毅.
欧盟和美国的平行科学建议制度对我国沟通交流制度的启示.
中国医药工业杂志,
2023
, 54
(8)
: 1259
-1264
.
DOI: 10.16522/j.cnki.cjph.2023.08.017
Siyao ZHANG, Yi LIANG.
Implications of the EMA-FDA Parallel Scientific Advice for China Communication System[J].
Chinese Journal of Pharmaceuticals,
2023
, 54
(8)
: 1259
-1264
.
DOI: 10.16522/j.cnki.cjph.2023.08.017
Year 2023 volume 54 Issue 8
13
1
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2023.08.017
- Receive Date:2023-05-26
- Online Date:2026-11-19
- Published:2023-08-10